ScienceIn the Pipeline

What's Next in Drug Discovery

Biopharmaceutical innovation is revolutionizing medical treatment and has ushered in a new era of medicine for patients. With nearly 7,000 medicines in development, 74 percent of which are potentially first-in-class, patients have more reasons to be optimistic than ever before. Medicines are being developed across dozens of therapeutic areas – including cancer, diabetes, cardiovascular, Alzheimer’s disease and more. Find out more about the potential of the biopharmaceutical R&D pipeline below.

Latest From TheBlog

IP Explained: Why IP protections are important for biologic medicines

By Tom Wilbur on July 18, 2019

Myvideopays member companies invested nearly $80 billion in R&D last year

By Tim McClung on July 18, 2019

Setting the record straight on international reference pricing

By Kevin Haninger on July 16, 2019

New Let's Talk About Cost TV ad asks: Why aren't patients sharing in savings at the pharmacy counter?

By Priscilla VanderVeer on July 9, 2019
https://www.biceps-ua.com/

https://www.avtomaticheskij-poliv.com.ua/

http://medicaments-24.com